Sanity Group is leading a change in the perception and regulation of cannabis across Europe. Centering on the untapped potential of cannabinoids for health, the company based in Berlin is bridging historical misconceptions with modern recognition of cannabis’s benefits.

Dual Approach: Medical Research And Consumer Wellness

Sanity Group tackles its mission from two angles: pushing the boundaries in medical cannabis research and elevating consumer wellness.

Their medical arm is pioneering in the realm of cannabis-based pharmaceuticals, with ambitions to become a top authority in European medical cannabis. Simultaneously, their consumer division is redefining wellness, introducing a range of products for a health-aware audience, and demonstrating the broad applications of non-psychoactive cannabinoids.

Educational Efforts To Reshape Views

A persistent hurdle in cannabis acceptance is its enduring stigma, which Sanity Group addresses directly. The company is committed to educational endeavors and advocacy, aiming to dismantle longstanding biases by underscoring cannabis’s …

Full story available on Benzinga.com